Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does low DHEA-S reduce androgen substrate availability in postmenopausal women?

Low circulating DHEA-S in postmenopausal women reduces the adrenal-derived substrate available for peripheral conversion into testosterone and dihydrotestosterone.

PlausibleJune 19, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Dehydroepiandrosterone sulfate is produced mainly by the adrenal glands and serves as a circulating precursor for peripheral conversion to testosterone and dihydrotestosterone, so low DHEA-S can reduce androgen substrate availability in postmenopausal women.

laying out figure…
9 of 10 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that DHEA-S is produced mainly by the adrenal zona reticularis and functions as a long-lived circulating reservoir that peripheral tissues convert into active androgens. The mechanism emphasizes SULT2A1-driven adrenal sulfation, steroid sulfatase and downstream enzymes enabling intracrine conversion, and age-related decline (adrenopause) that lowers substrate availability for androgen synthesis, although other adrenal or residual ovarian pathways may partially offset this loss in some women.

Verified conclusion

Dehydroepiandrosterone sulfate (DHEA-S) represents a cornerstone of the human steroidome, particularly as women transition through and beyond menopause. As ovarian follicular activity ceases, the body shifts its reliance for sex steroid production to a system of local synthesis fueled by circulating adrenal precursors.

Mechanisms of production and conversion

DHEA-S is almost exclusively produced in the zona reticularis of the adrenal cortex. This tissue-specific production is driven by the high expression of the enzyme SULT2A1, which sulfates DHEA into its more stable, circulating form.

  • The Prohormone Reservoir: DHEA-S acts as a massive reservoir, with circulating levels significantly higher than other steroids. Its long half-life allows it to reach peripheral tissues where it is converted into active androgens.
  • Intracrine Cascade: In peripheral tissues such as the skin, bone, and vaginal wall, the enzyme steroid sulfatase (STS) converts DHEA-S back into DHEA. A sequence of enzymes (3βHSD, 17βHSD, and 5α-reductase) then transforms this precursor into testosterone and ultimately dihydrotestosterone (DHT), the most potent androgen.

Clinical implications for postmenopausal women

For a 73-year-old woman, the adrenal contribution to the androgen pool is critical because the ovaries no longer produce significant estrogens, though they may still secrete some testosterone.

  • Adrenopause and Substrate Availability: DHEA-S levels decline by approximately 80% between the ages of 20 and 70. This decline, known as adrenopause, directly reduces the raw material available for peripheral tissues to synthesize their own androgens.
  • Androgen Buffering: While low DHEA-S reduces substrate availability, the impact on total androgenic activity is not always linear. Some women maintain androgen levels through continued ovarian secretion of testosterone or via the 11-oxygenated androgen pathway, an alternative adrenal route that does not rely on DHEA-S and remains relatively stable with age.

Bottom line

The adrenal glands are the primary source of DHEA-S, which serves as the essential raw material for peripheral androgen synthesis. In postmenopausal women, a decline in DHEA-S directly limits the substrate available for conversion into testosterone and DHT, although individual androgen status may be partially sustained by residual ovarian function and alternative adrenal pathways.

References

  1. Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. — pmc.ncbi.nlm.nih.gov ↗
  2. Testosterone Increases Circulating Dehydroepiandrosterone Sulfate Levels in the Male Rhesus Macaque — frontiersin.org ↗
  3. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency. — pmc.ncbi.nlm.nih.gov ↗
  4. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. — academic.oup.com ↗
  5. Nonhuman primates as models for human adrenal androgen production: Function and dysfunction — pmc.ncbi.nlm.nih.gov ↗
  6. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues — journals.lww.com ↗
  7. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment? — pmc.ncbi.nlm.nih.gov ↗
  8. Intracrine Formation of Steroid Hormones in Breast Cancer, Epidermal Keratinocyte, Dermal Fibroblast, and Adipocyte Cell Lines Measured by LC-MS/MS — pmc.ncbi.nlm.nih.gov ↗
  9. Insight on the intracrinology of menopause: androgen production within the human vagina. — endocrine-abstracts.org ↗
  10. Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration — pmc.ncbi.nlm.nih.gov ↗
  11. Hydrogen Peroxide Stimulates Dihydrotestosterone Release in C2C12 Myotubes: A New Perspective for Exercise-Related Muscle Steroidogenesis? — mdpi.com ↗
  12. Diagnostic pitfalls in ovarian androgen-secreting tumors in postmenopausal women with rapidly progressed severe hyperandrogenism — journals.sagepub.com ↗
  13. Changes in androstenedione, dehydroepiandrosterone, testosterone, estradiol, and estrone over the menopausal transition — pmc.ncbi.nlm.nih.gov ↗
  14. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. — academic.oup.com ↗
  15. Adrenal changes associated with adrenarche — pmc.ncbi.nlm.nih.gov ↗
  16. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. — pmc.ncbi.nlm.nih.gov ↗
  17. Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women. — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→